Description
Recombinant monoclonal antibody to CD69. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 2.8. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
Target
CD69
Target Alias Names
AIM, BL-AC/P26, EA1, CLEC2C, GP32/28, MLR-3, Early activation antigen CD69, Activation inducer molecule, C-type lectin domain family 2 member C, Early T-cell activation antigen p60, Leukocyte surface antigen Leu-23
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression